JoshuaPortnoyMD

Critical Care Medicine, Interstitial Lung Diseases

Owner of Colorado Pulmonary Intensivists, & Co-Director of ICU at Littleton Adventist Hospital

Dr. Portnoy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
15 W Dry Creek Cir
Littleton, CO 80120
Phone+1 303-952-1100

Fax+1 720-287-3183

University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1998 - 2001
McGill University Faculty of MedicineClass of 1995

CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2012

PubMed

51 citations
Respiratory bronchiolitis-interstitial lung disease: long-term outcome.
Joshua Portnoy, Kristen L. Veraldi, Marvin I. Schwarz, Carlyne D. Cool, Douglas Curran-Everett
Chest. 2007-03-01
17 citations
Alveolar type II cells inhibit fibroblast proliferation: role of IL-1α
Joshua Portnoy, Tianli Pan, Charles A. Dinarello, John M. Shannon, Jay Y. Westcott
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2006-02-01
50 citations
Keratinocyte growth factor stimulates alveolar type II cell proliferation through the extracellular signal-regulated kinase and phosphatidylinositol 3-OH kinase pathways.
Joshua Portnoy, Douglas Curran-Everett, Robert J. Mason
American Journal of Respiratory Cell and Molecular Biology. 2004-01-23